How the da Vinci SP system is changing selected breast cancer surgery workflows
MedStar Georgetown combines four breast procedures through one 4-centimeter robotic incision. Examine safety, sensation and clinical evidence.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Intuitive Surgical’s 14-million-case analysis strengthens da Vinci evidence but also exposes the economics debate
A meta-analysis covering more than 14 million procedures found several recovery advantages associated with da Vinci robotic surgery, while longer operating times and the study’s largely observational evidence base keep hospital economics central to the debate.
Medical Devices & Diagnostics
Medtronic’s latest Hugo clearance looks small, but LigaSure could matter enormously in the robotics economics race
FDA clearance for Medtronic’s LigaSure RAS Maryland instrument adds a familiar vessel-sealing technology to Hugo, strengthening the company’s effort to build a broader robotic surgery ecosystem around instruments, procedures and recurring revenue.
Medical Devices & Diagnostics
Johnson & Johnson finally has its surgical robot. Why OTTAVA’s smaller footprint may not be enough to unseat da Vinci
Johnson & Johnson has received FDA De Novo authorization for the OTTAVA robotic surgical system across multiple upper-abdominal procedures. Its table-integrated design could bring robotic surgery into smaller operating rooms, but clinical evidence, surgeon training and hospital economics will determine whether it can challenge Intuitive Surgical.
Medical Devices & Diagnostics
Momentis Surgical Anovo FDA clearance expands robotic surgery to multiport procedures
Momentis Surgical wins FDA clearance for Anovo multiport surgery, widening its robotic platform while adoption and evidence remain key.
Medical Devices & Diagnostics
CONMED’s AirSeal gains a crucial da Vinci 5 fit, but will hospitals change their robotic workflow?
See how CONMED’s AirSeal expansion to da Vinci 5 hex cannulas could influence robotic surgery workflows, adoption and recurring sales.
Medical Devices & Diagnostics
Johnson & Johnson has entered soft-tissue robotics, but can Ottava loosen da Vinci’s grip?
Johnson & Johnson can launch its table-integrated Ottava surgical robot in the United States, opening a new competitive front against Intuitive Surgical and Medtronic.
Medical Devices & Diagnostics
Johnson & Johnson clears a key OTTAVA hurdle, but the harder robotics test comes next
Robotic surgery is opening up. Johnson & Johnson’s OTTAVA data may test whether hospitals want a new soft tissue platform.